ALIM(Delisted)
Alimera SciencesยทNASDAQ
--
--(--)
ALIM Profile
Alimera Sciences, Inc.
A global pharmaceutical company develops ophthalmic pharmaceuticals that treat diseases affeting the back of the eye, or retina
6310 Town Square, Suite 400, Alpharetta, GA 30005
--
Alimera Sciences, Inc., founded in Delaware on June 4, 2003, is a biopharmaceutical company. The company specializes in the research and development of the commercial application of ophthalmic prescription drugs, and currently focuses on the disease infection of the rear eyeball structure and the retina. The company believes that these diseases are currently not well treated, and this represents a huge market to be developed.
